New Delhi: Several studies have already started in different parts of the world to test effectiveness of convalescent plasma therapy in treating COVID-19 patients.
The idea behind this therapy is that immunity can be transferred from a healthy person to a sick using convalescent plasma.
Convalescent plasma refers to plasma from recovered COVID-19 patients.
So in this therapy, blood is drawn from a person who has recovered from the disease and the serum is separated and screened for virus-neutralising antibodies.
When attacked by a pathogen, our immune systems produce antibodies and in this therapy these antibodies from recovered patients are used to treat other sick people.
According to Neha Gupta, Infectious Diseases Consultant at Fortis Memorial Research Institute in Gurugram, based on the type of severity of COVID 19 infection, immunity develops.
Immunity develops early in asymptomatic or persons with mild symptoms, while it develops later in severe and critically-ill COVID 19 patients, she explained.
The concept of this therapy dates back more than a century, when similar treatments were used during the Spanish flu pandemic of 1918, a diphtheria outbreak in the 1920s, a flesh-eating bacteria epidemic in the 1930s, and during other outbreaks of infectious diseases. It was tried most recently for Ebola. Effectiveness of the therapy has varied.
The process for donating plasma is similar to donating blood and takes about an hour, according to Houston Methodist which became the first academic medical centre in the US to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.
Plasma donors are hooked up to a small device that removes plasma while simultaneously returning red blood cells to their bodies. Unlike regular blood donation in which donors have to wait for red blood cells to replenish between donations, plasma can be donated more frequently, as often as twice a week, it said.
The Indian Council of Medical Research (ICMR) has given nod to Kerala to conduct plasma therapy.
Kerala is the first state in the country to have been given the nod to try this out, as a task force was already in place.
Earlier, a small study in China found the therapy effective in treating coronavirus patients. Positive results from China encouraged other countries including the US to test the effectiveness of the therapy against COVID-19.
For all the latest News, Opinions and Views, download ummid.com App.
Select Language To Read in Urdu, Hindi, Marathi or Arabic.
Malegaon Coronavirus: 4 new cases, 1 tests positive in Chandwad
Also Read
5 test positive for Coronavirus in Malegaon, 1 dead
Two from Malegaon test Coronavirus positive in UP's Bulandshahr
Ramadan 2020 likely to start in Saudi Arabia on April 23, a day later in India, Pakistan
Muslim wagers, vendors bear the brunt of Coronavirus-Tablighi Jamaat link
Apologise, Pay 1 cr in Damages: Tablighi Jamaat legal notice to Times Now
7-yr-old with no Tablighi Jamaat link among new Gujarat Coronavirus cases
India stares at 150th Coronavirus death, Positive cases get past 5000
14-month-old dies of Coronavirus in Gujarat, State death tally surges
At Delhi's Bhagirath Palace, its as if the lockdown has already ended
Don't give communal colour to Coronavirus: TN CM
Makkah, Madinah report 96 new cases; Saudi Corona deaths surge
City of the Prophet Madinah reports 02 Coronavirus deaths
Necessary to extend Coronavirus lockdown till June: KCR
India Coronavirus lockdown may not end on April 14
"It's horrible": Doctor fighting Corona describes grim conditions at NY hospitals
With 356 deaths, Holland is new Coronavirus epicenter in Europe
Close to 150,000 Americans infected by Coronavirus
Coronavirus Latest Alert: US could be new epicentre by April
USA Covid-19 count surges past China, Italy; New York worst affected
Govt, not Tablighi Markaz, to blame for Corona Pandemics deaths
Six die in Telangana after visiting Tablighi Markaz in Delhi Nizamuddin
Coronavirus: FIR against Maulana Saad Kandhalvi of Nizamuddin Tablighi Markaz